18th Apr 2019 11:31
LONDON (Alliance News) - SkinBioTherapeutics PLC on Thursday said it appointed Stuart Ashman to the board as an executive director with immediate effect.
Ashman will then succeed Cath O'Neill as chief executive officer following a period of transition, which will enable him to gain an understanding of the business and allow for an orderly handover.
This decision will also enable O'Neill to focus on the scientific development of the company, SkinBioTherapeutics, a firm focused on skin health said.
Prior to joining the company, Ashman served as CEO of Onbone Oy, a Finnish private equity-backed medical device company. Before that, he was president and CEO of Andover Healthcare Inc, a US-based wound management manufacturer.
SkinBio Therapeutics shares were trading 0.7% higher at 18.12 pence each.
Related Shares:
Skinbiotherap.